WO1993004197A1 - Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique - Google Patents

Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique Download PDF

Info

Publication number
WO1993004197A1
WO1993004197A1 PCT/BE1992/000033 BE9200033W WO9304197A1 WO 1993004197 A1 WO1993004197 A1 WO 1993004197A1 BE 9200033 W BE9200033 W BE 9200033W WO 9304197 A1 WO9304197 A1 WO 9304197A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
scrape
block
paraffin
situ hybridisation
Prior art date
Application number
PCT/BE1992/000033
Other languages
English (en)
Inventor
Marc Ramael
Eric Van Marck
Original Assignee
Universitaire Instelling Antwerpen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaire Instelling Antwerpen filed Critical Universitaire Instelling Antwerpen
Publication of WO1993004197A1 publication Critical patent/WO1993004197A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

Definitions

  • the invention relates to a method for detecting a virus in cell material of a scrape or body fluid by means of in situ hybridisation.
  • the in situ hybridisation technique is an efficient technique for detecting the presence of viruses and is at present routinely utilised on biopsy material.
  • the utilisation of this technique on scrapes on the other hand has little success in view of the problems which arise. With the known utilisation on scrapes these scrapes are directly smeared on a slide after which the in situ hybridisation is applied. There is however an absence of good adherence of the scrapes to the slide. Furthermore the amount of cytologic material is very limited while on the other hand a large amount of expensive test material is necessary in order to cover the slide, through which this method is very costly.
  • the invention is intended to remedy the aforementioned disadvantages and to provide a method for detecting a virus in cell material of a scrape or body fluid whereby the in situ hybridisation can be utilised in an economic manner and without problems both with regard to the amount of cell material and to adherence to slides.
  • a cell concentrate is prepared from a suspension of the scrape in a liquid medium, which suspension is first prepared in the case of a scrape, or from the body fluid, the cell concentrate is fixed and the fixed concentrate is embedded by means of the known histological embedding technique in paraffin or similar material, after which parts of the block obtained are subjected to the in situ hybridisation according to the known in situ hybridisation technique used with tissue sections.
  • the applicant has in startling manner determined that, by not performing the in situ hybridisation directly on a smear of scrape but on cells which are suspended, concentrated, fixed and emDedded in paraffin, the in situ hybridisation can be applied without problems in the same manner as with tissue sections whereby the detection of a virus in cells of a scrape, or of a body fluid such as blood,, in which case the suspension is obviously superfluous, can take place in a relatively easy and inexDensive way with a minimum of scrape or body fluid.
  • the suspension is preferably prepared with a phosphate buffered salt solution with a physiologic pH.
  • the cell concentrate is prepared by centrifuging, and the sediment obtained is further treated.
  • the cell concentrate before forming the paraffin block, is first embedded in a medium for forming a preparatory cell block and this cell block is later processed into a paraffin block.
  • hybridisation slices of the paraffin block are preferably mounted on slides pre-treated with adhesive.
  • paraffin blocks are first de-paraffined, subsequently they are subjected to an enzymatic pre-treatment, denatured, and finally they are subjected to the actual in situ hybridisation, after which the parts are washed and the virus detected by means of test material.
  • test kits available on the market destined for detecting a virus such as the papilloma virus in tissue.
  • this scrape is put into suspension in a phosphate buffered salt solution with a physiologic pH.
  • This suspension can temporarily be stored in a re rigerator.
  • a cell concentrate is prepared by centrifugmg the suspension at room temperature and the concentrate obtained, namely the sediment, is mixed with a viscous, hardly water-soluble medium such as an agar solution in distilled water at 60 degrees Celsius.
  • the solidified cell block which is obtained at room temperature after cooling off is put into neutral buffered formaldehyde solution (formalin) for fixing the cell material.
  • a paraffin block is prepared from this cell block with the assistance of a known tecnnique which is utilised with tissue sections. Moreover the cell block is first dehydrated by means of alcohol which is thereafter removed by means of a solvent. Subsequently this solvent is substituted in the cell block by melted paraffin which is subsequently allowed to solidify by cooling off.
  • Thin sections with a thickness of for example 5 micrometres, are cut from the paraffin block, and these sections are mounted on slides which are pre-treated with an adhesive such as 3-am ⁇ nopropylt ⁇ ethoxysiIan. In between the slices can be allowed to float on a protein-free water bath. After drying the sections, they are maintained for 12 hours at a temperature of 58 to 60 degrees Celsius, whereby the paraffin melts and a good adherence to the slides is achieved, after which they are kept dust-free for the time desired.
  • an adhesive such as 3-am ⁇ nopropylt ⁇ ethoxysiIan.
  • the actual detection of the papi1loma virus occurs according to the known in situ hybridisation technique, whereby the paraffin sections are treated in the same manner as tissue sections which are already routinely treated according to this technique.
  • test kits which are on the market normally for detecting the papilloma virus in tissue sections.
  • a number of sections are de-paraffined beforehand by means of a solvent such as xylene, after which they are rinsed with alcohol and dried in the air.
  • these sections are subjected to an enzymatic treatment with Proteinase £ in order to liberate the DNA from the cells in the sections.
  • test materials or probes are necessary of which a drop is applied respectively to three different slices.
  • a first test material contains marked papilloma virus DNA sequences.
  • a second, so-called positive DNA control test material is specifically for human genome DNA sequences and generates a hybridisation signal in human cells.
  • the third test material, the so-called negative DNA test material is specifically for a plasmid vector and normally produces no hybridisation signals.
  • a vector sequence present in this last test material does not hybridise with the DNA in human cells.
  • the DNA to be tested must be denatured, which occurs by maintaining the section for five to ten minutes at 100 degrees Celsius. If the DNA in the test material contains one single strand this denaturisation can take place before the test material is added. If the DNA in the test material is double stranded, which is usually the case, then the denaturisation is performed after adding the test material.
  • the hybridisation is performed for 18 to 24 hours at 37 degrees Celsius in a humid incubation chamber. Thereafter the excess test material is washed away from the sections.
  • a drop of detection reagent is applied to each section. After incubation at 37 degrees Celsius a substrate solution is applied and, after washing, a solution for staining. After again washing and dehydrating in alcohol the section is mounted in a mounting medium.
  • the method according to the invention was subsequently applied to scrapes from the exo- and endocervix from these women, which scrapes were separately dissolved in ten millilitres of a phosphate buffered salt solution at a pH of 7.4.
  • Each suspension was put into a plastic tube of 50 millilitres and centrifuged at 1000 revolutions per minute for 10 minutes at room temperature.
  • the sediment was mixed in a recipient with 0.1 millilitres of a 3% agar solution (bacteriological agar, GIBCO, U. K. ) in distilled water at 60 degrees Celsius. After cooling the cell block was removed from the recipient and transferred to a plastic embedding cassette (Lancer, USA). Fixation was performed for two hours in neutral buffered formalin at ro-om temperature.
  • the cell block was subsequently converted into a .paraffin block by means of the usual histological paraf in embedding techniques with the assistance of a Tissue-Tek II histokmette CLabtek, USA).
  • Sections of five micrometres were cut from the paraffin block which were allowed to float on a protein-free water bath. These sections were then adhered on slides pre- treated with 3-am ⁇ nopropyltriethoxysilan (Digene, USA). After drying at 37 degrees Celsius the sections were heated to 60 degrees Celsius and maintained for a night at this temperature.
  • the enzymatic treatment with proteinase K and the hybridisation were performed according to the instructions from the manufacturer by means of the so-called " Viratype in situ HPV tissue hybridisation kit " in combination with the so-called " Viratype in situ HPV omniprobe set " , both from Digene, U.S.A.
  • the omniprobe set contained three DNA test materials or probes namely a DNA test material, marked with biotin, for the papilloma virus HPV 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52 and 56, a positive control material specifically for frequently repeated sequences in the human genome and a negative control test material consisting of pBR 322 plasmid.
  • protemase £ digestion solution from the aforementioned kit was applied to the sections and the sections were incubated for three minutes at 37 degrees Celsius.
  • the hybridisation was performed in a humid incubation chamber for 18 hours at 37 degrees Celsius.
  • the covering plates were removed and the excess test material was rinsed away with a buffer.
  • Bonded test material was detected by means of a detection reagent bound with alkaline phosphatase. After washing with a buffer and incubating in a substrate solution of 5-bromo- 4-chloro-3-mdolyl phosphate and nitroblue tetrazolium at 37 degrees Celsius for 60 minutes and again washing with distilled water the sections were treated with a staining solution (nuclear fast) for 30 seconds. After washing with distilled water, dehydration in 95 degree ethanol and rinsing in xylene the sections were mounted in a mounting medium Pertex (Histolab, Sweden).
  • Sections incubated with the HPV test material that detects HPV serotypes 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52 and 56 showed a fine purple bluish granular signal in some nuclei of exocervical cells, mostly flattened cells presumably originating from the outer layers of the exocervical epithelium. With hematoxylin/eosin staining some of these cells had morphologic characteristics of koilocytes. The majority of the nuclei showed no reactivity and were faint pink red. Negative control sections incubated with pBR 322 plasmids showed no reactivity, which excluded the non-specific binding of the test material. Positive control sections showed in more than 90% of the nuclei a positive signal consisting of a purple bluish fine granular pattern.
  • the above described method is very reliable and fast. It only requires a small amount of test material, namely only 40 microlitres in order to cover a section with the ceils, as a result of which the method is also relatively inexpensive.
  • Another great advantage consists in that from one paraffin block originating from one scrape a very large number of sections are obtained while only three sections are necessary for a test. This permits if necessary to repeat the test or to perform other processes on the remaining part of the paraffin block for determining the virus such as polymerase chain reaction in order to confirm the test. It is further possible if desired to sub-typify the papilloma virus or to isolate the DNA from the remaining material of the paraffin block.
  • the method is not limited to the detection of the papilloma virus in cell material.
  • Other viruses such as the Epstein-Barr virus or the cytomegalovirus can be detected according to the method.
  • the method is also not limited to the testing of scrapes. It can also be applied to body fluids such as blood or a broncho-alveolar rinse.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Est décrit un procédé pour déterminer un virus dans la substance cellulaire d'un prélèvement ou d'un liquide organique, au moyen d'une hybridation in situ, caractérisé en ce que premièrement un concentré cellulaire est préparé à partir d'une suspension du prélèvement dans un milieu liquide, laquelle suspension est tout d'abord préparée dans le cas d'un prélèvement, ou bien à partir du liquide organique, le concentré cellulaire est fixé et le concentré fixé est inclus, à l'aide de la technique d'inclusion histologique connue, dans la paraffine ou une substance cellulaire, après quoi des parties du bloc obtenu sont soumises à l'hybridation in situ selon la technique d'hybridation in situ connue utilisée avec les coupes histologiques.
PCT/BE1992/000033 1991-08-13 1992-08-12 Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique WO1993004197A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9100738 1991-08-13
BE9100738A BE1005174A3 (nl) 1991-08-13 1991-08-13 Werkwijze voor het opsporen van een virus in celmateriaal van een afschraapsel of lichaamsvocht.

Publications (1)

Publication Number Publication Date
WO1993004197A1 true WO1993004197A1 (fr) 1993-03-04

Family

ID=3885649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE1992/000033 WO1993004197A1 (fr) 1991-08-13 1992-08-12 Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique

Country Status (3)

Country Link
AU (1) AU2378492A (fr)
BE (1) BE1005174A3 (fr)
WO (1) WO1993004197A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033333A2 (fr) * 2003-10-07 2005-04-14 Dako Denmark A/S Methodes et compositions pour le diagnostic de cancer
EP1688503A1 (fr) * 2003-10-20 2006-08-09 Sysmex Corporation Methode de traitement de cellules

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD264767A1 (de) * 1987-09-21 1989-02-08 Akad Wissenschaften Ddr Verfahren zum nachweis von papillomviren in menschlichen zervikalabstrichen
WO1989002934A1 (fr) * 1987-10-02 1989-04-06 Microprobe Corporation Diagnostic pour la detection de papillomavirus humains avec sondes de nucleotides
WO1990002204A1 (fr) * 1988-08-31 1990-03-08 Research Development Foundation METHODE MANUELLE D'HYBRIDATION $i(IN SITU)
WO1990010715A1 (fr) * 1989-03-07 1990-09-20 Molecular Biosystems, Inc. Hybridation in situ en suspension pour la detection ou la separation de cellules

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD264767A1 (de) * 1987-09-21 1989-02-08 Akad Wissenschaften Ddr Verfahren zum nachweis von papillomviren in menschlichen zervikalabstrichen
WO1989002934A1 (fr) * 1987-10-02 1989-04-06 Microprobe Corporation Diagnostic pour la detection de papillomavirus humains avec sondes de nucleotides
WO1990002204A1 (fr) * 1988-08-31 1990-03-08 Research Development Foundation METHODE MANUELLE D'HYBRIDATION $i(IN SITU)
WO1990010715A1 (fr) * 1989-03-07 1990-09-20 Molecular Biosystems, Inc. Hybridation in situ en suspension pour la detection ou la separation de cellules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF CLINICAL MICROBIOLOGY vol. 27, no. 11, November 1989, WASHGINGTON,D.C.,USA pages 2429 - 2432 C.A.GLEAVES ET AL. See the whole document, especially p. 2429, left column, lines 24-32 and right column, lines 22-30 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033333A2 (fr) * 2003-10-07 2005-04-14 Dako Denmark A/S Methodes et compositions pour le diagnostic de cancer
WO2005033333A3 (fr) * 2003-10-07 2005-07-07 Dako Denmark As Methodes et compositions pour le diagnostic de cancer
US8221970B2 (en) 2003-10-07 2012-07-17 Dako Denmark A/S Human papilloma virus probes for the diagnosis of cancer
US8513398B2 (en) 2003-10-07 2013-08-20 Dako Denmark A/S Human papilloma virus probes for the diagnosis of cancer
EP1688503A1 (fr) * 2003-10-20 2006-08-09 Sysmex Corporation Methode de traitement de cellules
EP1688503A4 (fr) * 2003-10-20 2007-10-31 Sysmex Corp Methode de traitement de cellules

Also Published As

Publication number Publication date
BE1005174A3 (nl) 1993-05-11
AU2378492A (en) 1993-03-16

Similar Documents

Publication Publication Date Title
US4483920A (en) Immobilization of message RNA directly from cells onto filter material
JP5132557B2 (ja) 外来微粒子の細胞透過性を向上させる方法
CA2332510C (fr) Procede d'hybridation in situ pour detection d'acides nucleiques cibles
JPH11503026A (ja) インジツーハイブリダイゼーション溶液及び方法
WO2001029265A1 (fr) Procede de detection de copies uniques de gene in situ
CN103940658A (zh) 一种组织细胞标本石蜡包埋的制作方法
AU5809799A (en) Removal of embedding media from biological samples and cell conditioning on automated staining instruments
JP2002524091A (ja) 架橋可能な固定化核酸を用いるアッセイ
Barletta et al. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection
JP5323261B2 (ja) 細胞又は組織試料の固定のためのビス−マレイン酸無水物架橋剤の使用
JPH10503655A (ja) ミコバクテリアの検出
CN111593146A (zh) 基于rna荧光原位杂交的高灵敏度单分子rna病毒检测方法
WO1993004197A1 (fr) Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique
CN108287097A (zh) 一种硫堇伊红染色液及制备方法和应用
Nuovo In situ localization of PCR-amplified DNA and cDNA
Pizard et al. Whole‐Mount In Situ Hybridization and Detection of RNA s in Vertebrate Embryos and Isolated Organs
Engler et al. Whole-mount in situ hybridization in plants
CN108195653A (zh) 一种复染染色试剂盒及制备和应用
JPH09127110A (ja) 測定法
WO2000024760A1 (fr) Detection de papillomavirus humain par le test de papanicolaou (pap)
Church et al. Non-isotopic in situ hybridization to detect chick Sox gene mRNA in plastic-embedded tissue
Murphy et al. Localization of foot and mouth disease virus RNA in tissue culture infected cells via in situ polymerase chain reaction
Howie et al. A non‐radiolabelled in situ hybridization method for the detection of epidermal cytokine mRNA
Mulder et al. Detection of early infection of swine vesicular disease virus in porcine cells and skin sections. A comparison of immunohistochemistry and in-situ hybridization
RU2777238C1 (ru) Способ флюоресцентной гибридизации in situ при применении ДНК-зонда с меткой FGFR1 у разных видов млекопитающих на гистологических препаратах

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase